RT Journal Article
SR Electronic
T1 Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e009432
DO 10.1136/jitc-2024-009432
VO 12
IS 6
A1 Iuliani, Michele
A1 Simonetti, Sonia
A1 Cristofani, Leonardo
A1 Cavaliere, Silvia
A1 Cortellini, Alessio
A1 Russano, Marco
A1 Vincenzi, Bruno
A1 Tonini, Giuseppe
A1 Santini, Daniele
A1 Pantano, Francesco
YR 2024
UL http://jitc.bmj.com/content/12/6/e009432.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.